GGrantIndex
Sort

85,873 grants matching alzheimers

Roles of ApoE4 in Brain Aging and Alzheimer's Disease

$3,284,440
Yadong Huang · J. David Gladstone Institutes · RF1 · FY2017 · AG

Leveraging 30 years of Alzheimer's disease clinical trials data to decipher phenotypic response to treatment

$3,281,385
Judy Pa · University Of California, San Diego · RF1 · FY2024 · AG

Understanding the Microbiome-gut-brain axisn Alzheimer disease and its Role in Cognitive Decline

$3,281,382
John Patrick Haran · Univ Of Massachusetts Med Sch Worcester · RF1 · FY2020 · AG

Integrative Biology Approach to Complexity of Alzheimer's Disease

$3,281,179
Eric E Schadt · Icahn School Of Medicine At Mount Sinai · U01 · FY2016 · AG

Clarifying the interplay between herpesvirus infection and reactivation, immune responses, APOE genotype, and development of tau-pathology

$3,280,861
Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health · RF1 · FY2025 · AG

Aging eyes and aging brains in studying alzheimer's disease: Modern ophthalmic data collection in the adult changes in thought (ACT) study

$3,280,202
Cecilia Sungmin Lee · University Of Washington · R01 · FY2023 · AG

SUGAR-seq: A New Technology for Single-Cell Glycan and Gene Expression Profiling in AD

$3,278,468
Linda C Hsieh-Wilson · California Institute Of Technology · RF1 · FY2018 · AG

The role of blood and brain 5-hydroxymethylcytosine in linking vascular risk factors to ADRD in older White and Black persons

$3,275,232
Zoe Arvanitakis · Rush University Medical Center · RF1 · FY2021 · AG

Reducing racial disparities in AD/ADRD: Addressing structural discrimination and resilience

$3,275,000
Sarah L Szanton · Johns Hopkins University · DP1 · FY2020 · AG

Administrative Core

$3,273,388
Vincent Mor · Brown University · U54 · FY2020 · AG

Autophagy in aging: testing geroscience in Alzheimer's disease

$3,272,577
Ana M. Cuervo · Albert Einstein College Of Medicine · P01 · FY2020 · AG

Olin Research Center: Addition for New MRI Scanner and Research Staff

$3,271,573
Harold I Schwartz · Hartford Hospital · C06 · FY2010 · RR

Cognition & Hippocampal/Cortical Systems in Aging

$3,270,599
Michela Gallagher · Johns Hopkins University · P01 · FY2024 · AG

Cognition & Hippocampal/Cortical Systems in Aging

$3,270,599
Michela Gallagher · Johns Hopkins University · P01 · FY2023 · AG

Spatial analysis of regional, cell type and molecular hallmarks of Alzheimer's disease and comorbid dementias.

$3,267,007
Jennie Leigh Close · Allen Institute · U19 · FY2025 · AG

A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial

$3,266,140
Mark Gregory Luciano · Johns Hopkins University · U01 · FY2024 · NS

Transitions to Family Caregiving and Its Impact on Health Indicators

$3,265,952
David L Roth · Johns Hopkins University · RF1 · FY2016 · AG

Olfactory dysfunction as predictor of PM2.5 exposure progression to dementia

$3,264,260
Zhekang Ying · University Of Maryland Baltimore · RF1 · FY2025 · AG

Autophagy in aging: testing geroscience in Alzheimer's disease

$3,262,353
Ana M. Cuervo · Albert Einstein College Of Medicine · P01 · FY2024 · AG

Autophagy in aging: testing geroscience in Alzheimer's disease

$3,262,353
Ana M. Cuervo · Albert Einstein College Of Medicine · P01 · FY2021 · AG

Autophagy in aging: testing geroscience in Alzheimer's disease

$3,262,353
Ana M. Cuervo · Albert Einstein College Of Medicine · P01 · FY2022 · AG

Autophagy in aging: testing geroscience in Alzheimer's disease

$3,262,353
Ana M. Cuervo · Albert Einstein College Of Medicine · P01 · FY2023 · AG

BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study

$3,262,056
E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2019 · AG

Wisconsin Longitudinal Study - Initial Lifetime's Impact on Alzheimer's Disease and Related Dementias (WLS-ILIAD Study)

$3,262,041
Sanjay Asthana · University Of Wisconsin-Madison · R01 · FY2019 · AG

The AD Knowledge Portal Data Coordination Center

$3,261,591
Laura Michelle Heath · Sage Bionetworks · U24 · FY2024 · AG